According to Nova One Advisor, the global Exoskeleton market gathered revenue around USD 499.45 million in 2024 and market is set to grow USD 2.25 billion by the end of 2034 and is estimated to expand at a modest CAGR of 16.29% during the prediction period 2025 to 2034.
Rapidly growing global geriatric population, increasing incidences of road accidents, rising prevalence of stroke is boosting the adoption of exoskeleton products and driving the market growth. As per National Safety Council data estimates in March 2021, 42,060 individuals have died in road accidents in 2025 and accounted for an increase of 8% as compared to 2024. Furthermore, the market is expected to witness the emergence of smarter & more competent exoskeletons through the integration of artificial intelligence and machine learning algorithms.
The mobile exoskeleton segment dominated in 2024 and is anticipated to grow lucratively over the forthcoming years owing to the emergence of innovative mobile exoskeletons for the disabled communities and geriatric population. Although, high costs and complications associated with mobile systems are expected to restrain the segment growth. The powered technology segment dominated in 2024 owing to the widespread adoption of powered exoskeletons for rehabilitation aid in patients suffering from spinal cord injuries.
This research report purposes at stressing the most lucrative growth prospects. The aim of the research report is to provide an inclusive valuation of the Exoskeleton market and it encompasses thoughtful visions, actualities, industry-validated market findings, historic data, and prognoses by means of appropriate set of assumptions and practice. Global Exoskeleton market report aids in comprehending market structure and dynamics by recognizing and scrutinizing the market sectors and predicted the global market outlook.
The report comprises the scrutiny of COVID-19 lock-down impact on the income of market leaders, disrupters and followers. Since lock down was instigated differently in diverse regions and nations, influence of same is also dissimilar across various industry verticals. The research report offers present short-term and long-term influence on the market to assist market participants across value chain makers to formulate the framework for short term and long-lasting tactics for recovery and by region.
Exoskeleton market Report empowers readers with all-inclusive market intelligence and offers a granular outline of the market they are operational in. Further this research study delivers exceptional combination of tangible perceptions and qualitative scrutiny to aid companies accomplishes sustainable growth. This report employs industry-leading research practices and tools to assemble all-inclusive market studies, intermingled with pertinent data. Additionally, this report also emphases on the competitive examination of crucial players by analyzing their product portfolio, pricing, gross margins, financial position, growth approaches, and regional occurrence.
Report Coverage | Details |
Market Size in 2025 | USD 1.74 Billion |
Market Size by 2034 | USD 2.79 Billion |
Growth Rate From 2025 to 2034 | CAGR of 5.4% |
Base Year | 2024 |
Forecast Period | 2025-2034 |
Segments Covered | Mobility, Technology, Extremity, End use, Region |
Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
Regional scope | North America; Europe; Asia Pacific; Latin America; MEA |
Key Companies Profiled | Ekso Bionics; Hocoma; Lockheed Martin Corporation; Suit X (U.S. Bionics, Inc.); Rex Bionics Plc.; RB3D; ReWalk Robotics Ltd; Cyberdyne, Inc.; and ActiveLink (Panasonic Corporation). |
The mobile segment dominated the market for exoskeleton and accounted for the largest revenue share of 60.7% and largest volume share of 61.7%. The mobile segment is anticipated to register the fastest growth rate over the forthcoming years.
This significant market share and lucrative growth rate is attributable to the surge in demand for motor-equipped robots for aiding human body mechanics and rise in research and development activities.
Key participants are constantly introducing innovative solutions for various industries which support worker/user’s health, boost productivity, reduce fatigue, and minimize risks of serious injuries. The growth witnessed by stationary exoskeleton technologies is due to the growing usage of stationary system in rehabilitation centers.
Year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
Mobile | 0.375 | 0.436 | 0.507 | 0.590 | 0.686 | 0.799 | 0.929 | 1.081 | 1.258 | 1.463 | 1.703 |
Fixed/Stationary | 0.125 | 0.145 | 0.168 | 0.195 | 0.227 | 0.264 | 0.306 | 0.355 | 0.413 | 0.479 | 0.556 |
The powered technology segment dominated the market for exoskeleton and accounted for the largest revenue share of 74.7% and volume share of 67.6% owing to the rising implementation of powered exoskeleton solutions in several industries to enhance personal safety and boost productivity.
Non-powered or passive technology segment is anticipated to register the fastest growth rate over the forthcoming years owing to the growing number of innovative product launches. For instance, in December 2024, Hilti partnered with Ottobock SE to launch EXO-O1, a passive exoskeleton used by the construction industry.
The lower body segment dominated the market for exoskeleton and accounted for the largest revenue share 43.3% and volume share of 53.5% owing to the alarming rise of lower body disabilities and growing adoption rates of exoskeleton products by paralyzed and geriatric population for stability, mobility, and weight-bearing capabilities.
The upper body segment is anticipated to register the fastest growth rate over the forthcoming years owing to the benefits provided by exoskeleton products in upper extremities such as supporting disabled communities and rehabilitation aid in post-stroke, neurological, or musculoskeletal impairments.
The healthcare segment dominated the market for exoskeleton and accounted for the largest revenue share of 51.3% and volume share of 51.8% owing to the rising incidence rate of Spinal Cord Injuries (SCIs), widespread adoption of these products and solutions in rehabilitation centers, and significant surge in treatment numbers are some of the key driving factors.
On the other hand, the industry segment is anticipated to register the fastest growth over the forthcoming years owing to the rising awareness levels towards the benefits associated with exoskeleton technologies in several industry applications and rapidly growing incidence rate of occupation-related injuries.
Year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
Healthcare | 0.225 | 0.262 | 0.305 | 0.355 | 0.413 | 0.481 | 0.560 | 0.651 | 0.758 | 0.883 | 1.028 |
Military | 0.150 | 0.174 | 0.202 | 0.235 | 0.273 | 0.317 | 0.369 | 0.428 | 0.498 | 0.578 | 0.672 |
Industry | 0.125 | 0.145 | 0.169 | 0.196 | 0.228 | 0.264 | 0.307 | 0.357 | 0.415 | 0.482 | 0.560 |
North America dominated the market for exoskeleton and accounted for the largest revenue share of 47.0% and volume share of 28.4% owing to the growing prevalence of disabled individuals, rising expenditure on research activities, growing public and private support, increasing number of partnerships & collaborations amongst key participants, and availability of technologically advanced products.
Asia Pacific is anticipated to register the fastest growth rate over the forthcoming years owing to growing patient pool requiring rehabilitation support. Developing & advancing healthcare infrastructure, availability of government support and funding are driving the development and growth of the market for exoskeleton in Asia Pacific.
Year | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 | 2034 |
North America | 0.175 | 0.204 | 0.237 | 0.276 | 0.321 | 0.374 | 0.436 | 0.507 | 0.591 | 0.688 | 0.801 |
Europe | 0.125 | 0.145 | 0.169 | 0.196 | 0.228 | 0.265 | 0.308 | 0.357 | 0.415 | 0.483 | 0.561 |
Asia-Pacific | 0.125 | 0.145 | 0.169 | 0.196 | 0.228 | 0.265 | 0.308 | 0.357 | 0.415 | 0.483 | 0.561 |
Latin America | 0.040 | 0.046 | 0.054 | 0.063 | 0.073 | 0.085 | 0.098 | 0.114 | 0.133 | 0.154 | 0.179 |
Middle East & Africa (MEA) | 0.035 | 0.041 | 0.047 | 0.055 | 0.064 | 0.074 | 0.086 | 0.100 | 0.116 | 0.135 | 0.157 |
Foremost players in the market are attentive on adopting corporation strategies to enhance their market share. Some of the prominent tactics undertaken by leading market participants in order to sustain the fierce market completion include collaborations, acquisitions, substantial spending in R&D and the improvement of new-fangled products or reforms among others.
Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.
Some of the prominent players in the Exoskeleton Market include: Ekso Bionics; Hocoma; Lockheed Martin Corporation; Suit X (U.S. Bionics, Inc.); Rex Bionics Plc.; RB3D; ReWalk Robotics Ltd; Cyberdyne, Inc.; and ActiveLink (Panasonic Corporation)
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for the period of 2021 to 2034 and covers subsequent region in its scope:
By Mobility
By Technology
By Extremity
By End-use
By Geography
North America
Europe
Asia Pacific
Latin America
Middle East & Africa (MEA)
Table 1: U.S. Exoskeleton Market, by Mobility, 2024–2034
Table 2: U.S. Exoskeleton Market, by Technology, 2024–2034
Table 3: U.S. Exoskeleton Market, by Extremity, 2024–2034
Table 4: U.S. Exoskeleton Market, by End-use, 2024–2034
Table 5: Canada Exoskeleton Market, by Mobility, 2024–2034
Table 6: Canada Exoskeleton Market, by Technology, 2024–2034
Table 7: Canada Exoskeleton Market, by Extremity, 2024–2034
Table 8: Canada Exoskeleton Market, by End-use, 2024–2034
Table 9: Mexico Exoskeleton Market, by Mobility, 2024–2034
Table 10: Mexico Exoskeleton Market, by Technology, 2024–2034
Table 11: Mexico Exoskeleton Market, by Extremity, 2024–2034
Table 12: Mexico Exoskeleton Market, by End-use, 2024–2034
Table 13: Germany Exoskeleton Market, by Mobility, 2024–2034
Table 14: Germany Exoskeleton Market, by Technology, 2024–2034
Table 15: Germany Exoskeleton Market, by Extremity, 2024–2034
Table 16: Germany Exoskeleton Market, by End-use, 2024–2034
Table 17: France Exoskeleton Market, by Mobility, 2024–2034
Table 18: France Exoskeleton Market, by Technology, 2024–2034
Table 19: France Exoskeleton Market, by Extremity, 2024–2034
Table 20: France Exoskeleton Market, by End-use, 2024–2034
Table 21: UK Exoskeleton Market, by Mobility, 2024–2034
Table 22: UK Exoskeleton Market, by Technology, 2024–2034
Table 23: UK Exoskeleton Market, by Extremity, 2024–2034
Table 24: UK Exoskeleton Market, by End-use, 2024–2034
Table 25: Italy Exoskeleton Market, by Mobility, 2024–2034
Table 26: Italy Exoskeleton Market, by Technology, 2024–2034
Table 27: Italy Exoskeleton Market, by Extremity, 2024–2034
Table 28: Italy Exoskeleton Market, by End-use, 2024–2034
Table 29: Rest of Europe Exoskeleton Market, by Segments, 2024–2034
Table 30: China Exoskeleton Market, by Mobility, 2024–2034
Table 31: China Exoskeleton Market, by Technology, 2024–2034
Table 32: China Exoskeleton Market, by Extremity, 2024–2034
Table 33: China Exoskeleton Market, by End-use, 2024–2034
Table 34: Japan Exoskeleton Market, by Mobility, 2024–2034
Table 35: Japan Exoskeleton Market, by Technology, 2024–2034
Table 36: Japan Exoskeleton Market, by Extremity, 2024–2034
Table 37: Japan Exoskeleton Market, by End-use, 2024–2034
Table 38: South Korea Exoskeleton Market, by Mobility, 2024–2034
Table 39: South Korea Exoskeleton Market, by Technology, 2024–2034
Table 40: South Korea Exoskeleton Market, by Extremity, 2024–2034
Table 41: South Korea Exoskeleton Market, by End-use, 2024–2034
Table 42: India Exoskeleton Market, by Mobility, 2024–2034
Table 43: India Exoskeleton Market, by Technology, 2024–2034
Table 44: India Exoskeleton Market, by Extremity, 2024–2034
Table 45: India Exoskeleton Market, by End-use, 2024–2034
Table 46: Southeast Asia Exoskeleton Market, by Segments, 2024–2034
Table 47: Rest of Asia Pacific Exoskeleton Market, by Segments, 2024–2034
Table 48: Brazil Exoskeleton Market, by Mobility, 2024–2034
Table 49: Brazil Exoskeleton Market, by Technology, 2024–2034
Table 50: Brazil Exoskeleton Market, by Extremity, 2024–2034
Table 51: Brazil Exoskeleton Market, by End-use, 2024–2034
Table 52: Rest of Latin America Exoskeleton Market, by Segments, 2024–2034
Table 53: GCC Countries Exoskeleton Market, by Mobility, 2024–2034
Table 54: GCC Countries Exoskeleton Market, by Technology, 2024–2034
Table 55: GCC Countries Exoskeleton Market, by Extremity, 2024–2034
Table 56: GCC Countries Exoskeleton Market, by End-use, 2024–2034
Table 57: Turkey Exoskeleton Market, by Segments, 2024–2034
Table 58: Africa Exoskeleton Market, by Segments, 2024–2034
Table 59: Rest of MEA Exoskeleton Market, by Segments, 2024–2034
Figure 1: U.S. Exoskeleton Market Share, by Mobility, 2024–2034
Figure 2: U.S. Exoskeleton Market Share, by Technology, 2024–2034
Figure 3: U.S. Exoskeleton Market Share, by Extremity, 2024–2034
Figure 4: U.S. Exoskeleton Market Share, by End-use, 2024–2034
Figure 5: Canada Exoskeleton Market Share, by Segments, 2024–2034
Figure 6: Mexico Exoskeleton Market Share, by Segments, 2024–2034
Figure 7: Germany Exoskeleton Market Share, by Mobility, 2024–2034
Figure 8: France Exoskeleton Market Share, by Segments, 2024–2034
Figure 9: UK Exoskeleton Market Share, by Segments, 2024–2034
Figure 10: Italy Exoskeleton Market Share, by Segments, 2024–2034
Figure 11: China Exoskeleton Market Share, by Mobility, 2024–2034
Figure 12: Japan Exoskeleton Market Share, by Segments, 2024–2034
Figure 13: South Korea Exoskeleton Market Share, by Segments, 2024–2034
Figure 14: India Exoskeleton Market Share, by Segments, 2024–2034
Figure 15: Brazil Exoskeleton Market Share, by Segments, 2024–2034
Figure 16: GCC Countries Exoskeleton Market Share, by Segments, 2024–2034
Figure 17: Turkey Exoskeleton Market Share, by Segments, 2024–2034
Figure 18: Africa Exoskeleton Market Share, by Segments, 2024–2034